Ipsos tracks opinions and intentions among consumers, healthcare professionals and other stakeholders to understand the rapidly shifting dynamics around COVID-19 vaccines and the future outlook through the eyes of society, markets and people.
Find our latest insights and opinions and an overview of our global vaccines research offer below.
Webinars and Videos
Building Better Insights Around the COVID Vaccine. Revisit our webinar to hear Ipsos’ healthcare experts discuss how insights from our research can be used to help inform different communities of interest including healthcare providers and pharmacists as well as the consumer populations in your market.
Our ethnography team have been following people across the world since the beginning of the pandemic to see how habits and behaviours have changed throughout the crisis. In the video below, we follow one participant in the UK as they take their mother to be vaccinated.
Polls & Reports
- Most adults vaccinated against COVID-19 in all 13 countries surveyed intend to get a booster shot. Still, most citizens view getting first doses of COVID vaccines to all who want them a greater priority than making booster shots available. 10 September 2021
- Post-COVID vaccination behaviours and return to activities. Confidence about returning to activities varies across nine countries surveyed says a new Ipsos study conducted in partnership with the World Economic Forum. 8 July 2021
- Majorities of unvaccinated adults in most of 15 countries would get a vaccine if they could. Survey also points to a decline in vaccination intent not only where many have already been inoculated. 25 May 2021
- Global public backs COVID-19 vaccine passports for international travel. Survey finds mixed views about mandating vaccine certificates for everyday activities. 28 April 2021
- Global attitudes : COVID-19 vaccines. COVID-19 vaccination intent has risen in the past few weeks. New Ipsos-World Economic Forum global survey highlights the increasing demand for COVID-19 vaccines and diverging views on whether vaccination should be mandatory. 9 February 2021
- U.S. and U.K. are optimistic indicators for COVID-19 vaccination uptake. New Ipsos-World Economic Forum survey following the release of a vaccine in the U.S. and U.K finds intentions to get vaccinated up in both countries, but down in several others as many worry about side effects. 29 December 2020
- Americans prioritize frontline workers for coronavirus vaccine. As the first coronavirus vaccine reaches approval for use in the United States, a new ABC News/Ipsos survey finds that Americans prioritize getting the vaccine to health care workers, first responders, and those most at risk. When it comes to themselves, most Americans say they are likely to get the vaccine eventually, but people are split on getting it as soon as possible versus waiting a while. 14 December
- Despite increase in COVID-19 cases this fall, Canadians continue to pull away from idea of mandatory vaccination. Most agree that front-line healthcare workers (62%) and first responders (52%) should receive first available doses. 28 November
- COVID-19 vaccination intent is decreasing globally. Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability - 5 November
- Coronavirus misinformation and reckless behaviour linked. New Axios-Ipsos poll in the U.S. shows celebrating upcoming holidays seen as somewhat risky – 20 October
- Interest in COVID-19 vaccine waning. New Newsy/Ipsos poll shows COVID-19 pandemic has bolstered support for public health funding, but not in the form of a tax increase in the USA – 25 September
- Two in three Americans likely to get coronavirus vaccine. New ABC News/Ipsos poll shows the number of Americans planning to get vaccinated, while still a majority, has declined from May – 20 September
- 3 in 4 Australians support mandatory COVID-19 vaccination. Following on from a recent Ipsos Study on behalf of the World Economic Forum which showed 88% of Australian adults surveyed would get a vaccine for COVID-19 if it were available, new data shows strong support for mandatory vaccination – 8 September
- Three in four adults globally say they would get a vaccine for COVID-19. Most do not expect any will be available before the end of year; fear of side effects is top reason for not wanting to take the vaccine – 1 September
- The race for a vaccine. In the turbulent times of COVID-19, businesses need to make critical decisions quickly. Synthesio and Ipsos are closely tracking millions of conversations to help our clients make informed, timely decisions – 20 August
- COVID-19 Vaccine Research. Almost three in four people would get COVID-19 vaccine, says Ipsos in Ireland survey for IPHA – 13 July
Articles & Papers
Attitudes to COVID-19 vaccines. The global rollout of COVID-19 vaccines will be the largest, fastest and most challenging vaccination program in history. This could bring many problems. Some we will anticipate; some we won’t. One glaring problem that is quickly emerging is a major mismatch between vaccine supply and demand.
Great expectations: Developments & dynamics of a COVID-19 vaccine – As the world awaits further news on outcomes from COVID-19 vaccine trials, we must acknowledge that the task of vaccinating the world against COVID-19 won’t be easy – especially when it comes to bringing the public on side. This paper uses Ipsos research to highlight the obstacles and opportunities that lie ahead, and the importance of building public support.
Vaccines hesitancy: Understanding belief formation – As we await the progress of COVID-19 vaccines, one question we can usefully consider now is how vaccination beliefs and behaviours are formed and maintained. This paper looks at the issue of vaccines hesitancy from a behavioural science perspective and asks whether the discussion to date has been overly focused on the individual, underestimating the role of cultural and political situations and other social drivers.
Click here to learn more about Ipsos’ global vaccines research capabilities, and how we can help answer your key questions: